← Back to AURA

Aura Biosciences, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 11/08/2026Mar 2026Filed 11/08/2026Sep 2025Filed 13/11/2025Jun 2025Filed 11/08/2026Mar 2025Filed 11/08/2026Sep 2024Filed 13/11/2025Jun 2024Filed 13/11/2025Mar 2024Filed 13/11/2025
−$46−$34−$26−$27−$27−$21−$20−$20
−$0.48−$0.50−$0.40−$0.47−$0.55−$0.42−$0.41−$0.40
9567665850505049

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.